Sunday, March 30, 2008 9:14:15 PM
Morrell et al.
Science Signaling 17 March 2008: 575-584
DOI: 10.1084/jem.20071474
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;1/12/ec114
Glutamate at the Clot
L. Bryan Ray
Science, Science Signaling, AAAS, Washington, DC 20005, USA
Glutamate is best known as a neurotransmitter, but glutamate is also present in the blood, and various glutamate receptors are found in tissues that include pancreatic β cells and bone cells. Morrell et al. add an important new target for glutamate regulation--platelets. Platelets store glutamate and have glutamate transporters, and Morrell et al. used a real-time enzymatic assay to show that glutamate was released during aggregation of human platelets induced in vitro with thrombin. Immunoblotting showed that platelets express AMPA (-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors. Glutamate alone did not cause platelet activation, but it did enhance activation in response to thrombin receptor-activating peptide (TRAP-6), and pharmacological studies indicated that glutamate acted through AMPA receptors. The authors used studies with Na+-sensitive dye and electrophysiological experiments to determine that AMPA receptor activation increased Na+ influx and promoted depolarization of the plasma membrane. Platelets respond to many regulators, and AMPA receptor activation enhanced the response of platelets to agonists that act through heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors. The authors also provided evidence from intravital microscopy to show that platelets from mice lacking the GluR1 subunit of the AMPA receptor had delayed thrombosis of experimentally damaged mesenteric arteries in vivo. Occlusion of arteries by thrombosis is a key mechanism in the deadly effects of cardiovascular disease and stroke. Thus, the authors suggest that AMPA receptors might provide a valuable new target for therapeutic inhibition of thrombosis.
C. N. Morrell, H. Sun, M. Ikeda, J.-C. Beique, A. M. Swaim, E. Mason, T. V. Martin, L. E. Thompson, O. Gozen, D. Ampagoomian, R. Sprengel, J. Rothstein, N. Faraday, R. Huganir, C. J. Lowenstein, Glutamate mediates platelet activation through the AMPA receptor. J. Exp. Med. 205, 575-584 (2008). [Abstract] [Full Text]
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM